Cargando…
Practical Challenges—Use of Paracetamol in Children and Youth Who are Overweight or Obese: A Narrative Review
Worldwide, > 380 million children and adolescents are overweight or obese, including 41 million children aged < 5 years. Obesity can change the pharmacokinetic properties of drugs by altering their distribution, metabolism, and elimination. Thus, children who are overweight or obese are at inc...
Autores principales: | Zempsky, William T., Bhagat, Preeti K., Siddiqui, Kamran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529628/ https://www.ncbi.nlm.nih.gov/pubmed/32918268 http://dx.doi.org/10.1007/s40272-020-00417-z |
Ejemplares similares
-
Common Selfcare Indications of Pain Medications in Children
por: Zempsky, William, et al.
Publicado: (2023) -
Treatment of children and adolescents who are overweight or obese
por: Di Figlia-Peck, Stephanie, et al.
Publicado: (2020) -
Overweight and Obesity in Children under 5 Years: Surveillance Opportunities and Challenges for the WHO European Region
por: Jones, Rebecca E., et al.
Publicado: (2017) -
Asthma medication in children who are overweight/obese: justified treatment?
por: Lentferink, Yvette E., et al.
Publicado: (2019) -
Exploring correlation between social determinants and overweight/obesity in children and youths with epilepsy
por: Yang, Jie, et al.
Publicado: (2022)